Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Shepherd

Showing results (111-120 of 384) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Predictors of referral for specialized psychosocial oncology care in patients with metastatic cancer: the contributions of age, distress, and marital statusJanet Ellis, Judy Lin, Andrew Walsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2009
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancerEric Vallières, Frances A Shepherd, John Crowley, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 8, 2009
Venous thromboembolism in patients receiving multimodality therapy for thoracic malignanciesApurva Patel, Masaki Anraku, Gail E Darling, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
Analysis of serum protein levels of angiogenic factors and their soluble receptors as markers of response to cediranib in the NCIC CTG BR.24 clinical trialChristina L Addison, Keyue Ding, Lesley Seymour, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 31, 2017
Tivantinib in Combination with Erlotinib versus Erlotinib Alone for EGFR-Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE StudyGiorgio V Scagliotti, Dale Shuster, Sergey Orlov, et al.
Journal of the National Cancer Institute|October 6, 2010
Re: Gene expression-based prognostic signatures in lung cancer: ready for clinical use?Paul C Boutros, Melania Pintilie, Thomas John, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2010
Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancerGiorgio Scagliotti, Thomas Brodowicz, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancerFarrah Kassam, Frances A Shepherd, Michael Johnston, et al.
Oncogene|October 19, 2002
Novel candidate tumor marker genes for lung adenocarcinomaKan-Kan Wang, Ni Liu, Nikolina Radulovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
Prognostic gene expression signature for squamous cell carcinoma of lungChang-Qi Zhu, Dan Strumpf, Chun-Yan Li, et al.
Pageof 39

Showing results (111-120 of 384) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Predictors of referral for specialized psychosocial oncology care in patients with metastatic cancer: the contributions of age, distress, and marital statusJanet Ellis, Judy Lin, Andrew Walsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2009
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancerEric Vallières, Frances A Shepherd, John Crowley, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 8, 2009
Venous thromboembolism in patients receiving multimodality therapy for thoracic malignanciesApurva Patel, Masaki Anraku, Gail E Darling, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
Analysis of serum protein levels of angiogenic factors and their soluble receptors as markers of response to cediranib in the NCIC CTG BR.24 clinical trialChristina L Addison, Keyue Ding, Lesley Seymour, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 31, 2017
Tivantinib in Combination with Erlotinib versus Erlotinib Alone for EGFR-Mutant NSCLC: An Exploratory Analysis of the Phase 3 MARQUEE StudyGiorgio V Scagliotti, Dale Shuster, Sergey Orlov, et al.
Journal of the National Cancer Institute|October 6, 2010
Re: Gene expression-based prognostic signatures in lung cancer: ready for clinical use?Paul C Boutros, Melania Pintilie, Thomas John, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 2, 2010
Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancerGiorgio Scagliotti, Thomas Brodowicz, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancerFarrah Kassam, Frances A Shepherd, Michael Johnston, et al.
Oncogene|October 19, 2002
Novel candidate tumor marker genes for lung adenocarcinomaKan-Kan Wang, Ni Liu, Nikolina Radulovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
Prognostic gene expression signature for squamous cell carcinoma of lungChang-Qi Zhu, Dan Strumpf, Chun-Yan Li, et al.
Pageof 39